Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cancer Genetics

4.61
0.0000
Volume:- -
Turnover:- -
Market Cap:48.69M
PE:-2.23
High:4.61
Open:4.61
Low:4.61
Close:4.61
Loading ...
Jan 28, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 28, 2021

Major Issues Report

8-K - Current report
Jan 14, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 08, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 08, 2021

Major Issues Report

8-K - Current report
Jan 07, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 07, 2021

Major Issues Report

8-K - Current report
Dec 03, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 03, 2020

Major Issues Report

8-K - Current report
Dec 03, 2020

Major Issues Report

8-K - Current report
Nov 20, 2020

Major Issues Report

8-K - Current report
Nov 12, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Nov 12, 2020

Major Issues Report

8-K - Current report
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Nov 02, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Nov 02, 2020

Major Issues Report

8-K - Current report
Nov 02, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 30, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 29, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses